We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Got them back for $20 Fx 1.2668.
24 to 20 = 16.5% over 48 days.
Today $14.26
March 19 (Reuters) - Tanker company Euronav (EUAV.BR), opens new tab will exit Belgium's blue-chip Bel-20 index after just two days of trading, as it no longer meets the membership conditions after its takeover by Compagnie Maritime Belge (CMB), bourse operator Euronext said on Tuesday.
CMB, owned by the Saverys family, and affiliates together hold 88.61% of the outstanding shares in Euronav, which exceeds the maximum allowed for the index.
"The Bel 20 rulebook prescribes that should the acquiring party own more than 85% of the shares, the company being acquired will exit the index," Euronext said.
Belgium's Euronav announced in October that its two major shareholders, CMB and Frontline (FRO.OL), opens new tab, had reached a deal that would see the Saverys family take control of the oil tanker company and buy its remaining shares.
That deal between CMB and peer Frontline came after the latter - controlled by Norwegian-born shipping tycoon John Fredriksen - in January 2023 scrapped a $4.2 billion merger plan with Euronav that would have created the world's largest publicly-listed tanker company.
Interesting tec chart site .
https://stockinvest.us/stock/EURN
Email from D offer only open to USA based holders.
Might then delist .
Forced to sell , be lucky to get a little more then tenner offer price .
Thank God I sold half the buy back for $19.69
15/2/2024
CMB has launched its mandatory takeover bid for Euronav, a test of shareholder appetite for its vision of a sustainability-focussed future for the company.
CMB’s bid for the outstanding shares in Euronav is the result of a deal made late last year to break a stalemate between Euronav and Frontline over the future of the tanker owner. Under the arrangement, CMB acquired a 26.12% stake in Euronav, bringing its total stake to 49%, 58% when its related parties are accounted for.
A takeover bid is mandatory when a shareholder takes its stake over 30%, and the CMB offer of $17.86 per share for the remaining 42% of the company will give an off-ramp for shareholders who lack confidence in the plan to transform Euronav into a diversified shipowner at the forefront of the decarbonisation of the industry.
Euronav shareholders agreed earlier this month to purchase CMB’s green ships and green technology arm CMB.TECH for $1.15bn. The company is set to be renamed CMB.TECH on closing of the takeover bid on March 15.
CMB’s has placed CMB.TECH and its 106 vessels within Euronav to foster ties within the companies and accelerate progress in the development and application of green solutions in the maritime industry.
“The intention of [CMB] is for Euronav to become the main entity within the CMB Group for low carbon marine and industrial applications and will focus on growing the future-proof fleet of the CMB Group,” the buyout prospectus said.
“By divesting less efficient/older tankers and re-investing the proceeds in newbuildings/modern second hand vessels or technical upgrades (e.g. energy saving devices), [CMB] wants to optimize Euronav’s large remaining fleet of tankers to continue offering the best fleet to its customers
Euronav will have priority on charters of over three months where Euronav and CMB vessels compete.
CMB said the benefits it saw from the takeover were a combination of its long term strategy and the financial strength and operational excellence of Euronav. For Euronav shareholders, the benefit is the bid price, said CMB, set at the level of $18.43 CMB paid for its stake in November, minus a $0.57 dividend per share.
Euronav’s fleet stands at 155 vessels, including those acquired with CMB.TECH. 104 ships are on the water and 51 are newbuild orders. The on the water fleet comprises two FSOs, 17 VLCCs, 22 suezmaxes, three newcastlemaxes, two container vessels, two chemical tankers, 53 CTV vessels, two passenger ferries and one tugboat.
Four VLCCs and four suezmaxes are under construction, as well as 23 newcastlemax and two coaster bulkers, six chemical tankers, four CTV vessels and five CSOV vessels
Sliced today for $14.. fx 1.265... 1.4% better rate then last sell. Share price 3.75% better then 27/12/23.
27/12/23 slice $13.5.. fx was 1.2828 .
In hindsight thank God I bought it back on the 8 % drop 2nd January 2024.
Good its 150% deal sizes.
They have my bep at 11.7891 higher then the 11.6895 on 27th December noted.
Sliced again at $24 had this target since end of January 2024.
Hard to believe this was $4.61 24th April 2023 just 10 months back.
Employees of TheStreet are prohibited from trading individual securities.
You're reading 1 of 1 free articles for this month.
Register now to get free access to more!
Might register in future if they call it correct ?
From The Street ! & UP 15% today.
Silence Therapeutics plc (SLN) was rated a new "outperform" (buy) at BMO Wednesday with a $67 price target. The company does cutting-edge work on medicines related to "RNA interference to inhibit the expression of specific target genes thought to play a role in the pathology of diseases.''
SLN has established partnerships with pharmaceutical companies, such as AstraZeneca (AZN) , Mallinckrodt Pharmaceuticals, and others.
Let's check out the charts and see .. not copied.
In this daily bar chart of SLN, below, I can see that prices have just rallied to a new 52-week high. Prices trade above the rising 50-day moving average line and above the bullish 200-day moving average line. Trading volume is light and uneven but the On-Balance-Volume (OBV) line has turned upwards.
The Moving Average Convergence Divergence (MACD) oscillator is above the zero line and poised for a fresh buy signal.
Image placeholder title
In this weekly Japanese candlestick chart of SLN, below, I see a bullish setup. Prices are in an uptrend and trade above the rising 40-week moving average line. The weekly OBV line has posted a strong advance the past three months. The MACD oscillator is in a bullish move above the zero line.
Image placeholder title
In this daily Point and Figure chart of SLN, below, I can see a price target in the $39 area.
Image placeholder title
In this second Point and Figure chart of SLN, below, I used weekly price data with a five box reversal filter and got a $25 price target so far.
Image placeholder title
Bottom line strategy: SLN is not particularly active. Trading volume is on the thin side so traders need to keep that in mind when entering orders. Wait for a pullback to $20. Risk to $15.
Bought that tranche back for $12.4.. fx1.259
Only 3 work days after the slice 8% drop .
Put me over booked funds as borrowed funds reduced yesterday .
150% deal sizes .
Munger also compared Robinhood to gambling, saying that its success is due to "people who know how to take advantage essentially of the gambling instincts of, not only American public, worldwide public"
Sliced today for $13.5.. fx1.2828
Did not post the slice 17/7/23 for $12.7
My bep 11.6895
Early November 2023 they fell back to $7.93 in hindsight what a good buy that would of been, near 75% gain in less then two months .
Took a slice today when noticed up 7% and above my $17 target got *$17.15 at 4.45pm .
Better if I had waited for today's top of $18.01 two hours later .
Still have two tranches after the USA switch , If it reaches $25 the London purchased ones will be up.
Correction 29/3/23 not 2022.
As are the two USA top ups on 29/3/22 at $7.435 and $7.
As are the two USA top ups on 29/3/23 at $7.435 and $7.
Went up 13.6% today .TYJ
Sold a tranche today for $10.5 , the 12/4/23 buy at $5.995 so a just over 75% gain.
The first USA top up 27/4/22 at $12.45 was sold 23/11/22 for $14.55 a 17% gain.
The second USA top up 15th just two & 16/6/22 at $8.2 now ahead .
As are the two USA top ups on 29/3/22 at $7.435 and $7.
The move to USA 15/3/22 .
Original London buy 5/2/21 was 582p = $25 *approx .
Sold the last tranche buy back today foe $11 fx 1.2828
fx rate not as good for seEling USA
Sold both three buys of three days ago back $5.5 6.30pm & $6 8pm sharp spike at 6pm to $7.24 at 7pm .
Fell back to close 6.57p up 34% on the day .
4.6 to 5.5 = 19.45% 5.3 to 6 = 13.3%
Bought another 100 shares $4.6.
Order lifted at 9pm all in one batch .
Bought another 100 shares $5.30.
Another on for $4.6 low showing $4.58
Bought another 100 shares $5.995 ( strait through on $6 limit )
Doubled up today's buy @ $7 executed 8pm on its way to $6.25.
Only $0.5 between my buys finished $1.1 below the second one .
Only news on line
Maybe this live webcast did not go down well .
( Has a page on Lse )
LONDON, March 29, 2023--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced that Company management will participate in a virtual fireside chat at Guggenheim’s Genomic Medicines and Rare Disease Days on Tuesday April 4th at 2:10 p.m. ET.
A live webcast of the presentation can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available on the Company’s website following the conference.
About Silence Therapeutics
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet need. Silence's proprietary mRNAi GOLD™ platform can be used to create siRNAs (short interfering RNAs) that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include SLN360 designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of lipoprotein(a) and SLN124 designed to address hematological diseases. Silence also maintains ongoing research and development collaborations with AstraZeneca, Mallinckrodt Pharmaceuticals, and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.
Bought 100 shares back today $7.435 strait through after removing the 98 shares for $7.5 order to adjust share size, both at 5pm had complacently wasted this Wednesday before that .
Saw it late on (D) did not notice $7.01 -12% .... 30 mins beforehand ( might not of wanted to pay the $7.5 if had )
Went back to $7.25 after before back to my $7.5 by 5.30pm
Delisted & moving to ADRs email 16/2/22
On 15/6/22 a part order, two lots of just 1 executed, so got 98 shares the next day for $8.2
23/11/22 sold above 100 executed in 5 "lots" for $14.55 ( Thank God as short of funds then )
27/4/22 I first bought the ADRs for $12.4 after the Transfer of just 57 shares 15/3/22 ( its one year on )
Got that tranche back today $9.9... fx 1.2129
USA Tech 100 down 2% this one down 3.3% on the day .
10.55 - 9.9 = 6% one day less then one week , interest rates to lend have increased to 4% ARP
Maybe do larger USA deals ?
Appears much less risky the London's AIM
Sold the tranche bought 9th November 2022 back for $10.55 Fx 1.2014 7pm had already left house .
More strength just before closing at $10.63